Jane Street’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-31,500
Closed -$538K 9448
2024
Q1
$538K Buy
+31,500
New +$495K ﹤0.01% 6535
2022
Q2
Sell
-6,800
Closed -$215K 9754
2022
Q1
$215K Sell
6,800
-7,900
-54% -$221K ﹤0.01% 8934
2021
Q4
$328K Buy
+14,700
New +$383K ﹤0.01% 8007
2021
Q3
Sell
-8,500
Closed -$331K 9982
2021
Q2
$331K Buy
8,500
+500
+6% +$17.9K ﹤0.01% 7974
2021
Q1
$230K Buy
+8,000
New +$273K ﹤0.01% 8077
2020
Q3
Sell
-18,000
Closed -$366K 7192
2020
Q2
$366K Buy
18,000
+7,200
+67% +$129K ﹤0.01% 5538
2020
Q1
$112K Buy
10,800
+1,800
+20% +$50.3K ﹤0.01% 4901
2019
Q4
$339K Buy
+9,000
New +$404K ﹤0.01% 4143
2018
Q4
Sell
-2,400
Closed -$278K 5001
2018
Q3
$278K Sell
2,400
-300
-11% -$33.8K ﹤0.01% 4309
2018
Q2
$341K Buy
+2,700
New +$329K ﹤0.01% 3992
2016
Q4
Sell
-6,700
Closed -$753K 4056
2016
Q3
$753K Buy
+6,700
New +$772K ﹤0.01% 2301

Other funds holding CLB

Jane Street's CLB Position: Q4 2025 in Review

Jane Street sold out of Core Laboratories (CLB) in Q4 2025, closing a stake of 59,305 shares — an estimated $733K sold.

Jane Street first reported a position in CLB in Q4 2015 and held it in 31 quarters. The position peaked at $6.62M in Q2 2020. 187 funds tracked by Wall St. Rank hold CLB as of Q4 2025.

  • Jane Street reported no remaining Core Laboratories position as of Q4 2025 after selling out during the quarter.
  • Jane Street sold 59,305 Core Laboratories shares in Q4 2025, an estimated $733K.
  • Jane Street first reported a position in Core Laboratories in Q4 2015 and held it in 31 quarters.
  • Jane Street's Core Laboratories position peaked at $6.62M in Q2 2020.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.